Publicação
Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment
| dc.contributor.author | Ferreira, Pedro L. | |
| dc.contributor.author | Luzeiro, Isabel | |
| dc.contributor.author | Lopes, Margarida | |
| dc.contributor.author | Jorge, André | |
| dc.contributor.author | Silva, Bruno | |
| dc.contributor.author | Ferreira, Lara | |
| dc.date.accessioned | 2021-03-08T23:32:22Z | |
| dc.date.available | 2021-03-08T23:32:22Z | |
| dc.date.issued | 2021-02-06 | |
| dc.date.updated | 2021-03-01T04:19:06Z | |
| dc.description.abstract | Background Migraine Disability Assessment Scale (MIDAS) is a useful tool to measure headache-related disability. Modified MIDAS with 4-week recall period reduces recall bias and improves accuracy of the results. This study aimed at validating mMIDAS in Portuguese. Methods Studied population consisted of adult migraine patients attending a headache outpatient clinic. Reliability was assessed by internal consistency and reproducibility in a 3-week test-retest. Content validity was evaluated by two expert panels. Construct validity was tested by comparing mMIDAS-P index in socioeconomic and clinical patient groups and scale unidimensionality was evidenced by factor analysis. Criterion validity was tested using EQ-5D-5L and HADS. Results Ninety-two patients, 88% female, mean age of 44 years, participated. They had, in average, 9.7 headache days in previous month, pain averaging 7.5/10. About 69.9% were on a migraine prophylactic treatment, and 42.4% had severe disability; 29.4 and 13.0% showed, respectively, moderate/severe anxiety and depression. Content validity showed that mMIDAS-P is simple and clinically useful. It did not show to be determined by patient’s sociodemographic characteristics and it was correlated with depression scale and EQ-5D-5L. Test-retest demonstrated high reproductive reliability and good internal consistency. Conclusion mMIDAS-P is valid and reliable. We strongly recommend it for clinical and research use. | pt_PT |
| dc.description.sponsorship | This project was funded by a research grant from Novartis Farma. The authors were not in any way influenced by this funding. This was only used for logistic purposes. CEISUC/CIBB is funded by national funds through FCT - Foundation for Science and Technology, I.P., under the Multiannual Financing of R&D Units 2020–2023. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | BMC Neurology. 2021 Feb 06;21(1):58 | pt_PT |
| dc.identifier.doi | 10.1186/s12883-021-02085-z | pt_PT |
| dc.identifier.issn | 1471-2377 | |
| dc.identifier.uri | http://hdl.handle.net/10400.1/15200 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | BioMed Central | pt_PT |
| dc.rights.holder | The Author(s) | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Patient reported outcomes | pt_PT |
| dc.subject | Quality of life | pt_PT |
| dc.subject | Migraine | pt_PT |
| dc.subject | mMIDAS-P | pt_PT |
| dc.subject | Productivity | pt_PT |
| dc.subject | Disability | pt_PT |
| dc.title | Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 1 | pt_PT |
| oaire.citation.startPage | 58 | pt_PT |
| oaire.citation.title | BMC Neurology | pt_PT |
| oaire.citation.volume | 21 | pt_PT |
| person.familyName | Ferreira | |
| person.givenName | Lara | |
| person.identifier.ciencia-id | 761A-3037-8E22 | |
| person.identifier.orcid | 0000-0003-2378-7750 | |
| person.identifier.rid | B-7575-2019 | |
| person.identifier.scopus-author-id | 24491766400 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | e93501ac-9707-4e92-bb2c-cc91bc09b428 | |
| relation.isAuthorOfPublication.latestForDiscovery | e93501ac-9707-4e92-bb2c-cc91bc09b428 |